Based on the Newsweek article about Interferon Alpha-2B Recombinant (IFNrec). Cuba and China have been experimenting with the drug with some positive results. The drug reportedly "'prevents aggravation and complications in patients reaching that stage
that ultimately can result in death,' Cuban biotech expert Luis Herrera
Martinez said, according to a recent Yale University Press Blog feature
written by the University of Glasgow's Helen Yaffe."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.